Value of disputed tax cases before appeals commission plummets by €2.85bn in 2021
Tax Appeals Commission closes 1,800 appeals
Perrigo
Drug company Perrigo welcomes settlement of record tax bill
Company will pay over money within seven days of formal agreement being signed
Perrigo agrees €300m settlement of €1.64bn tax assessment
Tax dispute dates back to a 2016 audit by Revenue
Former Davy chief executive McKiernan hits back at criticism of firm
Seen & Heard: RTÉ workers seek compensation; Beauparc’s waste margins
Perrigo boss on the largest tax bill ever issued by Revenue
Business interview: CEO Murray Kessler talks Covid and sorting out Perrigo’s Irish tax bill
Ireland's largest tax bill falls 40% to €976m
Revenue Commissioners and Perrigo have been in intense discussions for months
Department officials gave warning shared equity scheme would inflate house prices
Seen & Heard: Indoor dining push-back, Perrigo’s tax bill and Heineken’s new stout
Revenue rejects settlement offer on €1.64bn Perrigo tax bill
Consumer healthcare group hit with largest tax assessment ever issued by commissioners
Perrigo holds out prospect of cheer for Paschal Donohoe
Healthcare group edging closer to settling its outstanding €1.64 billion tax bill
Perrigo makes offer to Revenue on disputed €1.64bn tax bill
Amount is second-largest in the history of the State, behind only high-profile Apple case
Multinationals fret over ruling on intellectual property sale
Perrigo court case and ruling over €1.64bn tax bill has far-reaching implications
Perrigo mulls over appeal path to pursue on €1.64bn tax bill
US pharma giant says it is disappointed by High Court judgment
High Court to rule on €1.64bn Perrigo tax case next week
Judgment could have major implications well beyond the drug company
C&AG urges action to clear €3.75bn backlog on tax appeals
Cases at appeals commission at end 2019 on average had been in that process for at least two years
Perrigo plans €840m Irish restructuring of old Elan unit to pay dividend
US-based drugs giant plans to reconfigure its share capital to create a distributable reserve
Revenue says Perrigo is no ‘sacrificial victim’ over €1.6bn tax bill
Drug company not being ‘singled out’ in dispute over tax assessment, High Court told
Revenue tells court it was entitled to raise €1.64bn tax assessment against Perrigo
Tax collector maintains Perrigo owes the money because of its 2013 purchase of Elan
Perrigo tells court of ‘very high level of unfairness’ in €1.64bn tax bill
Pharma group challenging ‘surprise’ Revenue assessment in hearing via video link
Perrigo’s High Court challenge to €1.64bn tax bill to be heard remotely
US drug company case to be heard via video link due to Covid-19 courtroom restrictions
Revenue faces US drug company Perrigo over disputed €1.64bn tax bill
Irish tax authorities argue sale of drug for MS should have been treated as capital gain
Your business week: Election-hit Bank of Ireland to report results
Salesforce, Glanbia and CRH to report; Guaranteed Irish roadshow on future trends takes place in UCC
Perrigo has ‘better than 50% chance’ of winning Irish tax case
US analyst RBC upbeat about High Court challenge to €1.64bn charge over Tysabri
This Week in Business: Media and aviation giants report results
Darina Allen talks to women who don’t lunch, while the FT’s Martin Wolf talks transformation
Revenue overly ‘aggressive’ in tax reassessments, claims institute
Edmund Burke Institute says Ireland’s reputation for tax certainty is being undermined
Your business week: Flutter Entertainment to report earnings
CSO figures to give clearer insight into state of affairs for Irish car industry; Glanbia and Kerry Group to report
Nine firms disputing €2.5bn in tax sought by Revenue
Rulings in most cases unlikely this year as Tax Appeals Commission tackles backlog
Perrigo criticises Revenue move to reap back tax of €1.64bn
Tax bill linked to sale by Elan of its stake in multiple sclerosis drug Tysabri in 2013
RBC backs Perrigo over €1.6bn tax demand
Perrigo has repeatedly argued it will defend its position in the tax case, and denies Elan underpaid tax on the Tysabri deal
Perrigo files for judicial review of €1.6bn Revenue tax bill
Revenue should not have issued notice of amended assessment of liability, firm says
All eyes on loan growth as Bank of Ireland reports full-year results
This Week: Big week for banks as SME lending stays weak amid Brexit caution
Canadian pharma company appoints Dublin man to lead new Europe operation
Theratechnologies has appointed Conor Walshe to the role of general manager
Perrigo may shelve Irish expansion amid €1.6bn tax battle
Drugmaker’s CEO says it’s hard to run a business with a complex portfolio from US
Perrigo appeals €1.6bn Revenue tax demand
Pharma group understood to have filed documents to contest assessment
Perrigo shares rise as deadline for appealing €1.6bn Irish tax bill nears
Listed pharmaceutical giant has signalled its intention to appeal Revenue’s tax assessment
Bank plans to issue up to €10bn in debt could be dealt blow by hard Brexit
Seen & Heard: Average pay at Goodbody stockbrokers reached €138,000 last year
Government will fight to support Apple, but Perrigo must battle alone
Cliff Taylor: Contrasting approaches to tax bills show the delicate balance Ireland must strike
Shares in Perrigo slump to 9-year low
Company confirmed it faces Revenue demand for €1.64bn in back taxes
What could Ireland buy with Perrigo’s €1.64bn tax bill?
Money would cover the full cost of the National Children’s Hospital
Revenue issues tax demand of over €1.6bn to pharma giant Perrigo
Claim relates to a row over the amount of tax paid on the sale of a stake in a major drug
More than €2bn invested in commercial property market so far this year
Figures from Cushman & Wakefield show more than €505m invested in third quarter
New Sharp Building in Dublin 2 quickly sells for €56.3m
At 47,500sq ft, top-end office block at Hogan Place will show 4.4 per cent yield
Making millions: how Irish team hit $735m jackpot with overdose rescue drug
US opioid crisis helped growth of overdose rescue drug marketed by Adapt Pharma
Perrigo slashes guidance on weakness in prescription business
Dublin-domiciled company announces separation of prescription arm following review
Perrigo takes 12-year lease on 45,000sq ft at Hogan Place
New €20m six-storey block in Dublin 2 has parking for 40 cars and 56 bicycle spaces
Perrigo sells Tysabri rights to Royalty Pharma in €2.7bn deal
Dublin-domiciled group finally gets hold of MS drug revenue it initially pursed from Elan in 2013
Perrigo makes board changes under pressure from activist investor
Dublin-based drugmaker was urged last year to explore a sale of its prescription business
Perrigo to review options for multiple sclerosis drug Tysabri
CEO John Hendrickson says drug faces increased competition and potential for wider use has failed to materialise
Treasury Building share for sale for €33m
Purchaser of one-third of Treasury Building will get annual rent of €1.83m
Dublin-headquartered Perrigo buys Geiss, Destin & Dunn
Over-the-counter drug company buys US healthcare distributor for undisclosed sum
Perrigo shares slide as drugmaker slashes full-year forecast again
Company sales have halved since the company rejected Mylan takeover offer late last year
Failed Perrigo suitor Mylan sees revenues rise on generic drugs
Dutch-domiciled US group says it is still fully committed to planned $7.2bn takeover of Sweden’s Meda
Cantillon: Valeant swipes Papa from Perrigo
What Papa brings to the party is a depth of experience from over 30 years in the business
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices